Biotargets of Cancer in Current Clinical Practice

  • Mauro Bologna

Part of the Current Clinical Pathology book series (CCPATH)

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Paolo Aloisi, Francesco Martella, Davide Cerone, Giampiero Porzio
    Pages 1-18
  3. Keith D. Hunter, Robert Bolt
    Pages 19-59
  4. Laura D. Locati, Angela Greco, Maria Grazia Borrello, Maria Luisa Carcangiu, Paolo Bossi, Roberta Granata et al.
    Pages 61-91
  5. Giulio Metro, Lucio Crinò
    Pages 93-114
  6. Roberta Zappasodi, Massimo Di Nicola
    Pages 115-157
  7. Lia Ginaldi, Massimo De Martinis
    Pages 159-194
  8. Nadia Rucci, Luca Ventura, Anna Teti
    Pages 195-219
  9. Alex M. Reece-Smith, Simon L. Parsons, Sue A. Watson
    Pages 221-244
  10. David N. Church, Rachel Susannah Midgley, David J. Kerr
    Pages 245-272
  11. Yasunori Minami, Masatoshi Kudo
    Pages 273-287
  12. Andrea Tubaro, Daniele Santini, Cosimo De Nunzio, Alice Zoccoli, Michele Iuliano
    Pages 325-354
  13. Mauro Bologna, Carlo Vicentini
    Pages 355-380
  14. Jessica Wangui Oribabor, Allison Ambrosio, Cesar M. Castro, Michael J. Birrer
    Pages 381-401
  15. Annekathryn Goodman, Leslie S. Bradford, Leslie A. Garrett
    Pages 403-417
  16. Vivek Subbiah, Razelle Kurzrock
    Pages 419-438
  17. Kim H. T. Paraiso, Jobin K. John, Keiran S. M. Smalley
    Pages 439-468
  18. Adriano Angelucci, Edoardo Alesse
    Pages 469-515
  19. Marilena V. Iorio, Patrizia Casalini, Claudia Piovan, Luca Braccioli, Elda Tagliabue
    Pages 517-546

About this book

Introduction

Biotargets of Cancer in Current Clinical Practice presents an updated and reasoned review of the current status of knowledge concerning the major cancer types with a special focus on the current biomarkers, genes involved and the potential future targets of innovative therapies. The volume includes for each major cancer type, a comprehensive although concise discussion of epidemiology, affirmed and innovative biomarkers for diagnosis, and descriptions of the relevant genes for prognosis and (individualized) therapy through biotarget-specific new molecular treatments, with the latest information on the validation status of each novel biomarker. Individual chapters are dedicated to the major cancer types, plus a special chapter on metastasis. The present debate on patentability of genetic information applied to diagnostics and therapeutics of cancer is also discussed.

Keywords

Cancer Therapeutics Epidemiology Metastasis

Editors and affiliations

  • Mauro Bologna
    • 1
  1. 1.Chair of General Pathology, Department of Experimental MedicineUniversity of L’AquilaL'AquilaItaly

Bibliographic information

  • DOI https://doi.org/10.1007/978-1-61779-615-9
  • Copyright Information Springer Science+Business Media, LLC 2012
  • Publisher Name Humana Press
  • eBook Packages Medicine
  • Print ISBN 978-1-61779-614-2
  • Online ISBN 978-1-61779-615-9
  • About this book